Skip to NavigationSkip to content

Pharmafile - Medical Communications News

The top ten news stories this week are dominated by corporate scandals, with researchers finding that Coca-Cola paid an organisation of scientists to...
The US Government has announced additional funding into Sanofi and GlaxSmithKline’s efforts to develop a recombinant protein-based vaccine to the...
Celltrion's infliximab biosimilar Remsima scores approval for five different indications in Europe, UK Government secures 60 million doses of GSK and...
The financial details of the deal were not revealed, but the delivery of these reserved doses is due to take place in the first half of 2021, at the...
Janssen’s IL-12 and IL-23 inhibitor Stelara (ustekinumab) has had its approved indications expanded by the FDA to include the treatment of skin...
NICE has revealed that a combination of Merck KGaA’s Bavencio (avelumab) and Pfizer’s Inlyta (axitinib) will be made available as a first-line...
Japan’s biggest drug firm Takeda is said to be mulling plans to cut back its sales operations with a new restructuring programme as part of its...
Hydroxychloroquine continues its downwards spiral as Moderna's COVID vaccine secures a futher $472 million investment from the US Government. Read...
The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its targets...
Insulin manufacturer Eli Lilly has requested a $24 million tax break over the next 10 years as an investment into its diabetes care section.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches